NCT01594502View on ClinicalTrials.gov

Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

CompletedOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2015

Study Completion Date

July 31, 2016

Conditions
Prostate Cancer
Interventions
DRUG

Dutasteride

0.5 mg daily

DRUG

Placebo

Placebo Comparator

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Illinois at Chicago

OTHER

NCT01594502 - Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies | Biotech Hunter | Biotech Hunter